Pyramax pyronaridine-artesunate Treat complicated Malaria

Save ₦200

Price:
₦3,800 ₦4,000

Description

Pyramax is used to treat uncomplicated malaria, caused by two types of malaria parasites, Plasmodium falciparum and Plasmodium vivax. 'Uncomplicated' means the disease does not involve severe, life-threatening symptoms

Pyramax, a fixed-dose combination of pyronaridine and artesunate co-developed by MMV and Shin Poong Pharmaceutical Co. Ltd., South Korea, is the newest ACT combination to be approved by a Stringent Regulatory Authority. 

ADMINISTRATION

Mode of administration The dose should be taken orally once a day for three days with or without food. Dosage in adults and children Pyramax tablets should be taken orally as a single daily dose for three consecutive days. A granule formulation is available for children weighing between 5 kg to under 20 kg

Customer Reviews

Based on 2 reviews
100%
(2)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
R
Redacted
(redacted)

(redacted)

R
Redacted
(redacted)

(redacted)

Payment & Security

Recently viewed